Status
Please wait ...

Details for messenger / hormone: APOA5

EndoNet ID: ENH00547

To link to the content of EndoNet use the EndoNet ID that is given on the detail pages in the format ENX0000, where X is a place holder for the type of the component (e. g. R for receptor or C for anatomical structure).
As URL for the linking append this ID to the detail page for this type of component.
For an hormone that would be:

http://endonet.bioinf.med.uni-goettingen.de/hormone/ENH00000

It is also possible to use the search of EndoNet to link to the right detail page. The URL should look like

http://endonet.bioinf.med.uni-goettingen.de/search/ENC00000
If the search pattern is unambigious the user is directed to the corresponding detail page.

Synonyms

  • ApoA-V
  • APOA5
  • apolipoprotein A5
  • apolipoprotein A-V
  • regeneration-associated protein 3
  • RAP3

General information

  • APOAV is an important determinant of plasma TG and lipoprotein cholesterol, and is potentially a risk factor for cardiovascular disease. [1]
  • APOA-V plays a important role in modulating high-density lipoprotein maturation and cholesterol metabolism. [2]

Classification

Hormone function

  • metabolism
    • nutrient supply

    Chemical classification

    • hormone
      • genome-encoded
        • apoproteins

      Composition

      Sequence
      RKGFWDYFS QTSGDKGRV EQIHQQKMA 
      REPATLKDS LEQDLNNMN KFLEKLRPL 
      SGSEAPRLP QDPVGMRRQ LQEELEEVK 
      ARLQPYMAE AHELVGWNL EGLRQQLKP 
      YTMDLMEQV ALRVQELQE QLRVVGEDT 
      KAQLLGGVD EAWALLQGL QSRVVHHTG 
      RFKELFHPY AESLVSGIG RHVQELHRS 
      VAPHAPASP ARLSRCVQV LSRKLTLKA 
      KALHARIQQ NLDQLREEL SRAFAGTGT 
      EEGAGPDPQ MLSEEVRQR LQAFRQDTY 
      LQIAAFTRA IDQETEEVQ QQLAPPPPG 
      HSAFAPEFQ QTDSGKVLS KLQARLDDL 
      WEDITHSLH DQGHSHLGD P

      Links to other resources

      UniProt Q6Q788
      Ensembl ENST00000227665
      KEGG hsa:116519
      • Anatomical structure: hepatocyte

        • APOA5 is expressed in human hepatoma HepG2 cells with levels comparable with human primary hepatocytes. [3]

        Influenced by:

        • THRA1
          in hepatocyte
          • Treatment with T3 significantly increased APOA5 mRNA levels at 6 h, and a 2-fold induction was achieved after 24 h of T3 addition. [3]
        • THRB1
          in hepatocyte
          • T3-activated TRbeta1 enhanced the activity of APOA5 DR4-driven promoter constructs. [3]
          • Treatment with T3 significantly increased APOA5 mRNA levels at 6 h, and a 2-fold induction was achieved after 24 h of T3 addition. [3]
        • bile acid receptor
          in hepatocyte
          • Bile acids induce human apoAV promoter activity via FXR. [4]
        • LXR-alpha
          in hepatocyte
          • Co-transfection of SREBP-1c downregulates APOA5 promoter activity. [5]
        • PPAR-alpha
          in hepatocyte
          • Overexpression of PPAR-alpha enhances the activity of the human ApoA5 gene promoter. [4]

      Targets

      Cell
      No records found.
      Reference